Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Investigating genetic factors in leukemia development is crucial for understanding disease etiology.
• The murine double-minute 2 (MDM2) gene plays a role in cell cycle regulation and tumor suppression.
• Single-nucleotide polymorphisms (SNPs) can influence gene function and disease susceptibility.

Purpose of the Study:

• To systematically review and analyze the association between the SNP309 in the MDM2 gene promoter and leukemia susceptibility.
• To determine if the G allele or specific genotypes of SNP309 are risk factors for leukemia.

Main Methods:

• A comprehensive literature search was conducted across multiple databases for case-control studies published between 1990 and 2014.
• Inclusion and exclusion criteria were applied to screen relevant studies.
• Meta-analysis was performed using RevMan 5.0 and Stata 10.0 to calculate combined odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

• Ten case-control studies involving 1889 cases and 5707 controls were included.
• Carrying the G allele of SNP309 was associated with increased leukemia susceptibility (OR=1.24, 95% CI [1.06, 1.45]).
• The GG genotype showed a significantly higher risk of leukemia compared to GT+TT genotypes (OR=1.47, 95% CI [1.11, 1.96]).

Conclusions:

• The SNP309 polymorphism in the MDM2 gene promoter is significantly associated with leukemia susceptibility.
• The G allele of SNP309 is identified as a potential risk factor for leukemia development.